CORRELATIONS BETWEEN HYDROPHOBICITY AND NON-SPECIFIC PHARMACOLOGICAL EFFECTS BETA -ADRENOCEPTOR BLOCKING AGENTS.HELLENBRECHT D; GORTNER L.1976; POLISH. J. PHARMACOL. PHARM.; POLAND; DA. 1976; VOL. 28; NO 6; PP. 625-630; ABS. POL.; BIBL. 8 REF.Article

INFLUENCE OF ISOPRENALINE AND SALBUTAMOL ON THE THRESHOLD OF ELECTRICALLY INDUCED VENTRICULAR FIBRILLATION IN ANAESTHETIZED GUINEA PIGS = INFLUENCE DE L'ISOPRENALINE ET DU SALBUTAMOL SUR LE SEUIL DE LA FIBRILLATION VENTRICULAIRE INDUITE ELECTRIQUEMENT CHEZ LES COBAYES ANESTHESIESHELLENBRECHT D; GORTNER L.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 287; NO 2; PP. 227-232; BIBL. 12REF.Article

UNTERSUCHUNGEN ZUR ANWENDUNG EINES APERSONALEN UNTERRICHTS-PROGRAMMSFUER DAS FACH PHARMAKOLOGIE UND TOXIKOLOGIE = ETUDES DE L'UTILISATION D'UN PROGRAMME D'INSTRUCTION APERSONNEL EN PHARMACOLOGIE ET TOXICOLOGIEHELLENBRECHT D; MAI B.1975; MED. WELT; DTSCH.; DA. 1975; VOL. 26; NO 44; PP. 2027-2031Article

PREDICTION OF THE NON-SPECIFIC CARDIODEPRESSANT EFFECTS OF BETA -ADRENOCEPTOR BLOCKING AGENTS IN VITRO AND IN VIVO BY MEANS OF THE HANSCH ANALYSIS = PREVISION DES EFFETS CARDIODEPRESSEURS NON-SPECIFIQUES DES AGENTS BLOQUANTS LES BETA -ADRENOCEPTEURS IN VITRO ET IN VIVO AU MOYEN DE L'ANALYSE DE HANSCHHELLENBRECHT D; MULLER KF; GROBECKER H et al.1974; EUROP. J. PHARMACOL.; NETHERL.; DA. 1974; VOL. 29; NO 2; PP. 223-235; BIBL. 18REF.Article

Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesisHELLENBRECHT, D; SALLER, R.Arzneimittel-Forschung. 1986, Vol 36, Num 12, pp 1845-1849, issn 0004-4172Article

Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesisSALLER, R; HELLENBRECHT, D.Cancer treatment reports. 1985, Vol 69, Num 11, pp 1301-1303, issn 0361-5960Article

MEASUREMENT OF HYDROPHOBICITY, SURFACE ACTIVITY, LOCAL ANAESTHESIA, AND MYOCARDIAL CONDUCTION VELOCITY AS QUANTITATIVE PARAMETERS OF THE NON-SPECIFIC MEMBRANE AFFINITY OF NINE BETA -ADRENERGIC BLOCKING = MESURE DE L'HYDROPHOBICITE, DE L'ACTIVITE DE SURFACE, DE L'ANESTHESIE LOCALE ET DE LA VITESSE DE CONDUCTION CARDIAQUE COMME PARAMETRES QUANTITATIFS DE L'AFFINITE DE MEMBRANE NON SPECIFIQUE DE 9 BLOQUANTS BETA -ADRENERGIQUESHELLENBRECHT D; LEMMER B; WIETHOLD G et al.1973; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMAKOL.; GERM.; DA. 1973; VOL. 277; NO 2; PP. 211-226; BIBL. 1 P. 1/2Serial Issue

Quantitative structure-activity studies of β-adrenoceptor blocking drugs to decrease ventricular arrhythmias in guinea pigsGORTNER, L; HELLENBRECHT, D.Arzneimittel-Forschung. 1988, Vol 38, Num 12, pp 1796-1799, issn 0004-4172Article

MEMBRANE EFFECTS OF BETA-ADRENERGIC BLOCKING AGENTS: INVESTIGATIONS WITH THE FLUORESCENCE PROBE 1-ANILINO-8-NAPHTHALINE SULFONATE (ANS) AND ANTIHEMOLYTIC ACTIVITIES = LES EFFETS MEMBRANAIRES DES AGENTS BLOQUANTS BETA -ADRENERGIQUES: RECHERCHES AVEC LE REACTIF FLUORESCENT ANILINO-1 NAPHTALENE SULFONATE-8 (ANS) ET LES ACTIVITES ANTIHEMOLYTIQUESWIETHOLD G; HELLENBRECHT D; LEMMER B et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 12; PP. 1437-1449; BIBL. 1P.Serial Issue

Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulationSALLER, R; HELLENBRECHT, D; BUHRING, M et al.Journal of clinical pharmacology. 1986, Vol 26, Num 2, pp 115-119, issn 0091-2700Article

Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteersHILDEBRAND, M; HELLSTERN, A; HÜMPEL, M et al.European journal of drug metabolism and pharmacokinetics. 1990, Vol 15, Num 1, pp 19-26, issn 0378-7966, 8 p.Article

Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapyVOGT, C; HELLENBRECHT, D; SALLER, R et al.Oncology. 1993, Vol 50, Num 2, pp 81-85, issn 0030-2414Article

Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liverHELLSTERN, A; HELLENBRECHT, D; SALLER, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 733-736, issn 0004-4172Article

Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasisHELLSTERN, A; HELLENBRECHT, D; SALLER, R et al.European journal of clinical pharmacology. 1993, Vol 45, Num 5, pp 415-418, issn 0031-6970Article